Skip to main navigation Skip to search Skip to main content

AstraZeneca AB: Open-label, Uncontrolled, Single Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of AZD7442 in Pediatrics Participants Aged > 29 Weeks Gestational Age to < 18 Years

Project: Research

Project Details

StatusFinished
Effective start/end date07/27/22 → 12/1/24

Funding

  • AstraZeneca Pharmaceuticals LP: $28,467.50